Odile Mondesert
Overview
Explore the profile of Odile Mondesert including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
20
Citations
211
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gava F, Pignolet J, Dejean S, Mondesert O, Morin R, Agossa J, et al.
Cancers (Basel)
. 2021 Nov;
13(22).
PMID: 34830995
Characterization of the molecular mechanisms involved in tumor cell clustering could open the way to new therapeutic strategies. Towards this aim, we used an in vitro quantitative procedure to monitor...
2.
Bonnet J, Rigal L, Mondesert O, Morin R, Corsaut G, Vigneau M, et al.
Cell Div
. 2021 Jan;
16(1):2.
PMID: 33514388
Background: Cancer cell aggregation is a key process involved in the formation of tumor cell clusters. It has recently been shown that clusters of circulating tumor cells (CTCs) have an...
3.
Bernard D, Mondesert O, Gomes A, Duthen Y, Lobjois V, Cussat-Blanc S, et al.
Cell Cycle
. 2019 Mar;
18(8):795-808.
PMID: 30870080
Modeling and in silico simulations are of major conceptual and applicative interest in studying the cell cycle and proliferation in eukaryotic cells. In this paper, we present a cell cycle...
4.
Gava F, Rigal L, Mondesert O, Pesce E, Ducommun B, Lobjois V
BMC Cancer
. 2018 Feb;
18(1):221.
PMID: 29482519
Background: Cancer cell aggregation is a key process involved in the formation of clusters of circulating tumor cells. We previously reported that cell-cell adhesion proteins, such as E-cadherin, and desmosomal...
5.
Mondesert O, Frongia C, Clayton O, Boizeau M, Lobjois V, Ducommun B
PLoS One
. 2015 Jul;
10(7):e0134411.
PMID: 26225756
Monitoring the DNA-Damage Response (DDR) activated pathway in multicellular tumor spheroid models is an important challenge as these 3D models have demonstrated their major relevance in pharmacological evaluation. Herein we...
6.
Boutros R, Mondesert O, Lorenzo C, Astuti P, McArthur G, Chircop M, et al.
PLoS One
. 2013 Jul;
8(7):e67822.
PMID: 23840880
CDK-cyclin complexes regulate centriole duplication and microtubule nucleation at specific cell cycle stages, although their exact roles in these processes remain unclear. As the activities of CDK-cyclins are themselves positively...
7.
Laurent J, Frongia C, Cazales M, Mondesert O, Ducommun B, Lobjois V
BMC Cancer
. 2013 Feb;
13:73.
PMID: 23394599
Background: MultiCellular Tumor Spheroid (MCTS) mimics the organization of a tumor and is considered as an invaluable model to study cancer cell biology and to evaluate new antiproliferative drugs. Here...
8.
Boutros R, Lorenzo C, Mondesert O, Jauneau A, Oakes V, Dozier C, et al.
Biol Cell
. 2010 Nov;
103(2):55-68.
PMID: 21091437
Background Information: CDC25 (cell division cycle 25) phosphatases function as activators of CDK (cyclin-dependent kinase)-cyclin complexes to regulate progression through the CDC. We have recently identified a pool of CDC25B...
9.
Kolb S, Goddard M, Loukaci A, Mondesert O, Ducommun B, Braud E, et al.
Eur J Med Chem
. 2009 Dec;
45(3):896-901.
PMID: 19969400
We report herein the synthesis of 5-substituted [1]pyrindine derivatives and the evaluation of their antiproliferative properties on HeLa cells, a cervical carcinoma tumor cell line, and on the melanoma A2058...
10.
Kolb S, Mondesert O, Goddard M, Jullien D, Villoutreix B, Ducommun B, et al.
ChemMedChem
. 2009 Feb;
4(4):633-48.
PMID: 19212959
The development of CDC25 phosphatase inhibitors is an interesting approach toward new antitumor agents, as CDC25 play key roles in cell-cycle regulation and are overexpressed in numerous cancers. We previously...